Vergani, Andrea <br/><br/>
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.  [electronic resource] 

 -  Diabetes  Sep 2010 
 - 2253-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db09-1264  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antilymphocyte Serum<br/>Autoimmunity--immunology<br/>Cell Division--immunology<br/>Cytokines--blood<br/>Diabetes Mellitus, Type 1--immunology<br/>Enzyme-Linked Immunosorbent Assay<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Islets of Langerhans Transplantation--immunology<br/>Mice<br/>Mice, Inbred NOD<br/>Ovalbumin--immunology<br/>Skin Transplantation--immunology<br/>Transplantation, Homologous